Simulated estimates of number of silicosis cases and annual tuberculosis (TB) cases at cumulative RCS distributions of increasing mean values. by Patrick Howlett (2612374)

“…<p>Silicosis prevalence and TB incidence was estimated for sample sizes of 10,000 at mean RCS values between 0 and 20, at intervals of 0.01 mg/m³-year. Variables in the model are held constant, unless otherwise stated, at values of: a baseline silicosis prevalence of 2%, an increased odds of 1.3 of silicosis per 1 mg/m³-year increase in RCS exposure, a baseline TB incidence of 200 cases per 100,000 per year, an increased odds of 1.05 of TB per 1 mg/m³-year increase in RCS exposure, an increased odds of TB of 4x in those with silicosis, a randomly distributed baseline prevalence of HIV of 2% and an increased odds of TB of 4x in those with HIV. …”

Parameters values for the baseline scenario correspond to the posterior median value <i>β</i>_<i>base</i> = 0.31, <i>ω</i>_<i>base</i> = 0.12, λ<sub><i>v</i>1</... by Maria L. Daza–Torres (12568896)

Subjects:

<i>RTTN</i>-mutated organoids exhibit decreased proliferation and increased cell death at early stages. by Justine Guguin (9088672)

Daily confirmed COVID-19 cases (n = 61,993) and smoothed trends for the median age of all the cases, hospitalized cases, and deceased cases. by Diego Casas-Deza (11819838)

Subjects:

Monthly trends in laboratory confirmed cases of malaria and malaria incidence from Nagongera Health Center. by Moses R. Kamya (8308617)

Forecasts of cancer patients’ medical use and expenditure (income/admission cases). by Jinah Sim (15140709)

Subjects:

Forecasts of cancer patients’ medical use and expenditure (income/outpatient cases). by Jinah Sim (15140709)

Subjects:

Excel spreadsheet including, in separate sheets, all numerical values used for Figs 1, 2, 3, 4 and S1. by Carla Maia (349844)

Temporal distribution of COVID-19 confirmed cases: Hospitalised cases and deaths. by Imelda Sonia Nzinnou Mbiaketcha (14670572)

Subjects:

Case #3 by Bálint Lakatos (10535348)

Increases in alert level and improved border measures resulted in decreases in secondary transmissions. by Alex James (2916851)

Decreasing trends in HbA1c are visible when using the average HbA1c for each dataset for T1Ds, but not T2Ds. by Hans F. Dias (14486401)

Daily PCR-confirmed COVID-19 cases (top). by Diego Casas-Deza (11819838)

Subjects:

GO analysis of stage-salient genes in the order of decreasing significance (i.e, increasing p–value). by Sangeetha Muthamilselvan (8966006)

“…<p>GO analysis of stage-salient genes in the order of decreasing significance (i.e, increasing p–value).</p>…”

Predictive value of RVT1 for the decreased RV ejection fraction (RVEF) and poor outcome in pulmonary arterial hypertension (PAH). by Ryotaro Asano (11767131)

“…(b) Relationships between changes in the RVEF and baseline RVT1. (c) The receiver characteristics curve analysis for a decreased RVEF at follow-up. …”

CHIKV-infected primary joint tissue fibroblasts display decreased MHC-I cell surface expression. by Brian C. Ware (8544672)

COVID-19 case selection flowchart. by Wendy Nieto-Gutierrez (6029735)

Subjects:

Rounds 3 and 4 of the bi-weekly total number of infected COVID-19 cases in Canada. by Mo’tamad H. Bata (13844697)

Subjects:

Case #5 by Bálint Lakatos (10535348)

Case #2 by Bálint Lakatos (10535348)